Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Comment by quinlashon Feb 25, 2024 11:59am
127 Views
Post# 35897858

RE:RE:RE:RE:Canopy Growth Institutional Ownership

RE:RE:RE:RE:Canopy Growth Institutional Ownership
Wheatkingtrad3r wrote: Thanks.  I'd feel better if those holding percentages were higher.  We need to see some confidence in Canopy from these funds.       


We also need to consider the reality that reports for insider trading and institutional ownership lag behind being made public for days, weeks and even months. Depending on who updates the fastest but also on what data is being reported.

Examples:

Insider trading - can update in hours or days depending on when the insider themselves report the transaction

Price to Sales Data - depending on the source this data can lag by weeks or months and is most accurate after a QTR report but again depends on when the person responsible for the updated data actually makes the update.

Anyone taking a critical view of stock websites should be noticing that it is not difficult to find numbers that are underdstated between what is reported on the QTR reports.  

Examples

Sharecount - some sites still report a much higher sharecount than actual shares outstanding

Price to Book Value + Ratio - you can compare websites to see this differs depending on who is reporting based on what data is used.  The easiest way to get the correct number is to do the math yourself based on the actual QTR report from Canopy

The list goes on but regardless the point is that much of the Bearish view may be contributed to outdated data (IMHO).

Canopy has been releasing a ton of new products, incremental sales and cash flow from these new products are being overlooked and with Germany now opening up we have not seen any speculation on how Canopy Medical will benefit from this. 

The company itself is not obligated to comment on this however it is entirely possible they will comment / issue a News Release if / when Canopy Medical secures a supply agreement with Germany.





















<< Previous
Bullboard Posts
Next >>